← All trials
NCT01665651
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2012
- Primary completion
- May 1, 2017
- Completion date
- May 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Shanghai University of Traditional Chinese MedicineLead sponsor
- Shanghai University of Traditional Chinese MedicineOverall official - principal investigator
- Shanghai University of Traditional Chinese MedicineSponsor investigator
- Fudan UniversityCollaborator
- Shanghai UniversityCollaborator
- Anhui College of Traditional Chinese MedicineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.